Have a personal or library account? Click to login
Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury Cover

Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury

Open Access
|Jan 2026

References

  1. M. Li, M. Liu, Y. Shang, C. Ren, J. Liu, H. Jin and Z. Wang, The substitution of a single amino acid with its enantiomer for control over the adjuvant activity of self-assembling peptides, RSC Adv. 10(23) (2020) 13900–13906; https://doi.org/10.1039/C9RA10325B
  2. M. Abdulbagi, L. Wang, O. Siddig, B. Di and B. Li, d-amino acids and d-amino acid-containing peptides: Potential disease biomarkers and therapeutic targets?, Biomolecules 11(11) (2021) Article ID 1716 (14 pages); https://doi.org/10.3390/biom11111716
  3. A. A. Ageeva, A. B. Doktorov, N. E. Polyakov and T. V. Leshina, Chiral linked systems as a model for understanding d-amino acids influence on the structure and properties of amyloid peptides, Int. J. Mol. Sci. 23(6) (2022) Article ID 3060 (18 pages); https://doi.org/10.3390/ijms23063060
  4. A. Jilek and G. Kreil, d-amino acids in animal peptides, Monatsh. Chem. 139 (2008) 1–5; https://doi.org/10.1007/s00706-007-0780-5
  5. P. Conti, L. Tamborini and A. Pinto, Drug discovery targeting amino acid racemases, Chem. Rev. 111(11) (2011) 6919–6946; https://doi.org/10.1021/cr2000702
  6. E. Rosini, P. D’Antona and L.Pollegioni, Biosensors for d-amino acids: Detection methods and applications, Int. J. Mol. Sci. 21(13) (2020) Article ID 4574 (16 pages); https://doi.org/10.3390/ijms21134574
  7. P. Turcic, M. Bradamante, K. Houra, N. Stambuk, T. Kelava, P. Konjevoda, S. Kazazic, D. Vikic--Topic and B. Pokric, Effects of alpha-melanocortin enantiomers on acetaminophen-induced hepatotoxicity in CBA mice, Molecules 14(12) (2009) 5017–5026; https://doi.org/10.3390/molecules14125017
  8. C. Jia, C. B. Lietz, Q. Yu and L. Li, Site-specific characterization of d-amino acid containing peptide epimers by ion mobility spectrometry, Anal. Chem. 86 (2014) 2972–2981; https://doi.org/10.1021/ac4033824
  9. M. V. Humpola, R. Spinelli, M. Erben, V. Perdomo, G. G. Tonarelli, F. Albericio and A. S. Siano, d- and N-methyl amino acids for modulating the therapeutic properties of antimicrobial peptides and lipopeptides, Antibiotics 12(5) (2023) Article ID 821 (15 pages); https://doi.org/10.3390/antibiotics12050821
  10. G. Murtas and L. Pollegioni, d-amino acids as novel blood-based biomarkers, Curr. Med. Chem. 29(24) (2022) 4202–4215; https://dx.doi.org/10.2174/0929867328666211125092438
  11. Y. Shi, Z. Hussain and Y. Zhao, Promising application of d-amino acids toward clinical therapy, Int. J. Mol. Sci. 23(18) (2022) Article ID 10794 (18 pages); https://doi.org/10.3390/ijms231810794
  12. G. Murtas and L. Pollegioni, d-Amino acids and cancer: Friends or foes?, Int. J. Mol. Sci. 24(4) (2023) Article ID 3274 (12 pages); https://doi.org/10.3390/ijms24043274
  13. R. P. Millar, Y. F. Zhu, C. Chen and R. S. Struthers, Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: Therapeutic implications, Br. Med. Bull. 56(3) (2000) 761–772; https://doi.org/10.1258/0007142001903346
  14. J. M. Cullen and M. Cascella, Physiology, Enkephalin, in StatPearls [Internet], StatPearls Publishing, Treasure Island 2025; https://www.ncbi.nlm.nih.gov/books/NBK557764/N
  15. J. Tian, W. Fu, Z. Xie, Y. Zhao, H. Yang and J. Zhao, Methionine enkephalin (MENK) protected macrophages from ferroptosis by downregulating HMOX1 and ferritin, Proteome Sci. 22 (2024) Article ID 2 (15 pages); https://doi.org/10.1186/s12953-024-00228-x
  16. X. Wang, S. Li, S. Yan, Y. Shan, X. Wang, Z. Jingbo, Y. Wang, F. Shan, N. Griffin and X. Sun, Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment, Int. Immunopharmacol. 111 (2022) Article ID 109125 (12 pages); https://doi.org/10.1016/j.intimp.2022.109125
  17. V. Asokan, A. M. Koundinya and V. Aranganathan, An overview of opioid peptides: Their sources and molecular sequences, J. Opioid Management 21 (2025) 439–459; https://doi.org/10.5055/jom.0954Y
  18. Y. Tuo, C. Tian, L. Lu and M. Xiang, The paradoxical role of methionine enkephalin in tumor responses, Eur. J. Pharmacol. 882 (2020) Article ID 173253 (10 pages); https://doi.org/10.1016/j.ejphar.2020.173253
  19. N. Qu, R. Wang, Y. Meng, N. Liu, J. Zhai and F. Shan, Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor, Int. Immunopharmacol. 110 (2022) Article ID 108933 (10 pages); https://doi.org/10.1016/j.intimp.2022.108933
  20. R. Martinić, H. Šošić, P. Turčić, P. Konjevoda, A. Fučić, R. Stojković, G. Aralica, M. Gabričević, T. Weitner and N. Štambuk, Hepatoprotective effects of Met-enkephalin on acetaminophen-induced liver lesions in male CBA mice, Molecules 19(8) (2014) 11833–11845; https://doi.org/10.3390/molecules190811833
  21. B. D. Janković and D. Marić, Enkephalins as Regulators of Inflammatory Immune Reactions, in Neuropeptides and Immunoregulation (Ed. B. Scharrer, E. M. Smith and G. B. Stefano) Springer-Verlag, Berlin 1994, pp. 76–100.
  22. X. Bai, F. Shan, N. Qu, H. Huang, M. Handley, N. Griffin, S. Zhang and X. Cao, Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma, Int. Immunopharmacol. 99 (2021) Article ID 107996 (6 pages); https://doi.org/10.1016/j.intimp.2021.107996
  23. P. Konjevoda, N. Štambuk, G. Aralica and B. Pokrić, Cytoprotective effects of met-enkephalin and α-MSH on ethanol induced gastric lesions in rats, J. Physiol. (Paris) 95(1–6) (2001) 277–281; https://doi.org/10.1016/s0928-4257(01)00038-9
  24. N. Štambuk, N. Kopjar, K. Šentija, V. Garaj-Vrhovac, D. Vikić-Topić, B. Marušić-Della Marina, V. Brinar, M. Trbojević-Čepe, N. Žarković, B. Ćurković, Ð. Babić-Naglić, M. Hadžija, N. Zurak, Z. Brzović, R. Martinić, V. Štambuk, P. Konjevoda, N. Ugrinović, I. Pavlić-Renar, Z. Biđin and B. Pokrić, Cytogenetic effects of Met-enkephalin (peptid-M) on human lymphocytes, Croat. Chem. Acta 71(3) (1998) 591–605; https://hrcak.srce.hr/132370
  25. D. Tjesić-Drinković, N. Štambuk, D. Tjesić-Drinković, P. Konjevoda, N. Gotovac, T. Ćurović and A. Votava Raić, Met-enkephalin effects on histamine-induced bronhoconstriction in guinea pigs, Coll. Antropol. 29(2) (2005) 689–692; https://hrcak.srce.hr/5330
  26. P. Konjevoda, N. Štambuk, D. Vikić-Topić, A. Boban-Blagaić, S. Vikić-Topić, V. Mrljak, J. Pavan, P. Ramadan and Z. Biđin, Protective effects of met-enkephalin on alcohol induced gastric lesions, Croat. Chem. Acta 73(4) (2000) 1111–1121; https://hrcak.srce.hr/131992
  27. A. D. Miller, Sense-antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science, Expert Opin. Biol. Ther. 15(2) (2015) 245–267; https://doi.org/10.1517/14712598.2015.983069
  28. K. Hinz, M. Niu, H. M. Ni and W. X. Ding, Targeting autophagy for acetaminophen-induced liver injury: An update, Livers 4(3) (2024) 377–387; https://doi.org/10.3390/livers4030027
  29. F. Guarner, N. K. Boughton-Smith, G. J. Blackwell and S. Moncada, Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse, Hepatology 8(2) (1988) 248–253; https://doi.org/10.1002/hep.1840080210
  30. H. Jaeschke and A. Ramachandran, Acetaminophen hepatotoxicity: Paradigm for understanding mechanisms of drug-induced liver injury, Annu. Rev. Pathol. 19 (2024) 453–478; https://doi.org/10.1146/annurev-pathmechdis-051122-094016
  31. P. Turcic, N. Stambuk, P. Konjevoda, T. Kelava, M. Gabricevic, R. Stojkovic and G. Aralica, Modulation of γ2-MSH hepatoprotection by antisense peptides and melanocortin subtype 3 and 4 receptor antagonists, Med. Chem. 11(3) (2015) 286–295; https://dx.doi.org/10.2174/1573406410666140914161421
  32. V. M. Silva, C. Chen, G. E. Hennig, H. E. Whiteley and E. J. Manautou, Changes in susceptibility to acetaminophen-induced liver injury by the organic anion indocyanine green, Food Chem. Tox. 39(3) (2001) 271–278; https://doi.org/10.1016/s0278-6915(00)00138-1
  33. K. Houra, P. Turčić, M. Gabričević, T. Weitner, P. Konjevoda and N. Štambuk, Interaction of α-melanocortin and its pentapeptide antisense LVKAT: Effects on hepatoprotection in male CBA mice, Molecules 16(9) (2011) 7331–7343; https://doi.org/10.3390/molecules16097331
  34. N. Štambuk, Z. Manojlović, P. Turčić, R. Martinić, P. Konjevoda, T. Weitner, P. Wardega and M. Gabričević, A simple three-step method for design and affinity testing of new antisense peptides: An example of erythropoietin, Int. J. Mol. Sci. 15(6) (2014) 9209–9223; https://doi.org/10.3390/ijms15069209
  35. H. Gampp, M. Maeder, C. J. Meyer and A. D. Zuberbühler, Calculation of equilibrium constants from multiwavelength spectroscopic data-I: Mathematical considerations, Talanta 32(2) (1985) 95–101; https://doi.org/10.1016/0039-9140(85)80035-7
  36. H. Gampp, M. Maeder, C. J. Meyer and A. D. Zuberbühler, Calculation of equilibrium constants from multiwavelength spectroscopic data-II132, 95.: Specfit: Two user-friendly programs in basic and standard FORTRAN 77, Talanta 32(4) (1985) 257–264; https://doi.org/10.1016/0039-9140(85)80077-1
  37. H. Gampp, M. Maeder, C. J. Meyer and A. D. Zuberbühler, Calculation of equilibrium constants from multiwavelength spectroscopic data-IV: Model-free least-squares refinement by use of evolving factor analysis, Talanta 33(12) (1986) 943–951; https://doi.org/10.1016/0039-9140(86)80233-8
  38. V. Blagaić, K. Houra, P. Turčić, N. Stambuk, P. Konjevoda, A. Boban-Blagaić, T. Kelava, M. Kos, G. Aralica and F. Culo, The influence of α-, β-, and γ-melanocyte stimulating hormone on acetaminophen induced liver lesions in male CBA mice, Molecules 15(3) (2010) 1232–1241; https://doi.org/10.3390/molecules15031232
  39. H. Jaeschke, Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity, Expert Opin. Drug Metab. Toxicol. 1(3) (2005) 389–397; https://doi.org/10.1517/17425255.1.3.389
  40. S. D. Nelson and S. A. Bruschi, Mechanisms of Acetaminophen-induced Liver Disease, in Drug-Induced Liver Disease (Ed. N. Kaplowitz and L. D. DeLeve), Informa Healthcare, New York 2007, pp. 353–388.
  41. E. J. Calabrese and L. A. Baldwin, Hormesis: The dose-response revolution, Annu. Rev. Pharmacol. Toxicol. 43 (2003) 175–197; https://doi.org/10.1146/annurev.pharmtox.43.100901.140223
  42. T. P. Khaket, J. Singh, P. Attri and S. Dhanda, Enkephalin degrading enzymes: Metalloproteases with high potential for drug development, Curr. Pharm. Des. 18(2) (2012) 220–230; https://doi.org/10.2174/138161212799040547
  43. N. Štambuk, P. Konjevoda, A. Boban-Blagaić and B. Pokrić, Molecular recognition theory of the complementary (antisense) peptide interactions, Theory Biosci. 123(4) (2005) 265–275; https://doi.org/10.1016/j.thbio.2005.02.001
  44. J. C. Biro, The proteomic code: A molecular recognition code for proteins, Theor. Biol. Med. Model. 4 (2007) 1–45; https://doi.org/10.1186/1742-4682-4-45
  45. M. García-Domínguez, Enkephalins and pain modulation: Mechanisms of action and therapeutic perspectives, Biomolecules 14 (2024) Article ID 926 (23 pages); https://doi.org/10.3390/biom14080926
  46. N. Štambuk, P. Konjevoda, P. Turčić, H. Šošić, G. Aralica, D. Babić, S. Seiwerth, Ž. Kaštelan, R. Novak Kujundžić, P. Wardega, J. Barać Žutelija, A. Gudelj Gračanin and M. Gabričević, Targeting tumor markers with antisense peptides: An example of human prostate specific antigen, Int. Mol. Sci. 20(9) (2019) Article ID 2090 (20 pages); https://doi.org/10.3390/ijms20092090
DOI: https://doi.org/10.2478/acph-2025-0036 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 659 - 672
Accepted on: Dec 12, 2025
|
Published on: Jan 13, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2026 Petra Turčić, Roko Martinić, Nikola Štambuk, Tin Weitner, Mirna Momčilović, Alenka Boban-Blagaić, Marina Kos, Ranko Stojković, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.